Showing results (161-170 of 218) with videos related to
Sort By:
Pageof 22
Journal of Hepatology|July 13, 2004
Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma developmentHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.Current Drug Abuse Reviews|July 28, 2009
Potential role of ADAMTS13 in the progression of alcoholic hepatitisMasahito Uemura, Yoshihiro Fujimura, Tomomi Matsuyama, et al.Oncology Reports|July 7, 2009
Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activitiesRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.Hepatology (Baltimore, Md.)|March 27, 2002
Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinomaHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.Journal of Angiogenesis Research|August 25, 2010
The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failureTadashi Namisaki, Hitoshi Yoshiji, Ryuichi Noguchi, et al.Alcoholism, Clinical and Experimental Research|March 3, 2007
Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitisTomomi Matsuyama, Masahito Uemura, Masatoshi Ishikawa, et al.Journal of Gastroenterology|November 1, 2011
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative studyYoshiyuki Narahara, Hidenori Kanazawa, Choitsu Sakamoto, et al.World Journal of Gastroenterology|November 16, 2006
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis CHitoshi Yoshiji, Ryuichi Noguchi, Hideyuki Kojima, et al.Journal of Gastroenterology and Hepatology|October 26, 2005
Sclerotherapy for gastric fundal variceal bleeding: is complete obliteration possible without cyanoacrylate?Kuniyuki Kojima, Hiroo Imazu, Masahiko Matsumura, et al.Molecular Medicine Reports|November 26, 2014
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis modelAkitoshi Douhara, Kei Moriya, Hitoshi Yoshiji, et al.Pageof 22